| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2021 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 000 | 1 | NIH | 3/4/2024 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $1,299,502 ) |
| 2023 | 2023 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 002 | 3 | NIH | 8/1/2023 | $1,249,502 |
| 2023 | 2023 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 001 | 2 | NIH | 4/19/2023 | $50,000 |
| 2023 | 2022 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 000 | 2 | NIH | 11/2/2022 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,249,502 ) |
| 2022 | 2022 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 000 | 2 | NIH | 9/9/2022 | $1,249,502 |
|
 | Issue Date FY: 2021 ( Subtotal = $449,821 ) |
| 2021 | 2021 | CURE NETWORK DOLBY ACCELERATION PARTNERS LLC | 1650 OWENS ST | SAN FRANCISCO | CA | 94158-2261 | SAN FRANCISCO | USA | R44AG071137 | Development of Nav1.1 Enhancers to Treat Alzheimer's Disease | 000 | 1 | NIH | 8/10/2021 | $449,821 |
|
|